Due to the advantages in improving insulin resistance, it may represent an adequate treatment in women with GDM, due to the need of guarantee an adequate glycaemic control and reduce the risk of maternal/perinatal complications in these patients, avoiding the risk of hypoglycaemic events that patients may experience with insulin treatment. Here, INS is linked to gestational diabetes.